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Abstract 
      Polycystic Ovary Syndrome (PCOS) have an increased risk of a number of gynecological 
neoplasms including endometrial cancer. It is expected that Moringa oleifera can decrease the 
expression of IGF-1, androgen receptor expression and endometrial thickness. We aimed to prove 
the effect of Moringa oleifera leaf extract in various doses to IGF-1 expression, expression of 
androgen receptor and endometrial thickness in PCOS-insulin resistance model. 
      We used 40 female Rattus norvegicus of Wistar strains weighing 100-130 grams aged 3 
months as samples, were divided into 5 groups including normal control group, PCOS control 
group, PCOS group with Metformin treatment and PCOS were given Moringa oleifera of leaf extract 
in two doses.  
      Moringa oleifera leaf extract have significantly decreased IGF-1 expression (P=.000). Moringa 
oleifera leaf extract have shown significantly decreased the expression of androgen receptors 
(P=.000). Moringa oleifera leaf extract has decreased the thickness of endometrium significantly 
(P=.000). 
      Moringa oleifera of leaf extract could decrease the expression of IGF-1 and expression of 
androgen receptors so that it could also decrease the thickness of endometrium in PCOS-Insulin 
Resistence model. 
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 Introduction 
 
Polycystic Ovarium Syndrome (PCOS) is 
a frequent problem of reproductive endocrinology 
that remains controversial. Clinical symptoms 
vary but usually include oligo-ovulation or 
anovulation, hyperandrogenism (both clinical and 
biochemical) and the presence of polycystic 
ovaries.1 Based on current PCOS criteria, about 
4-6% of women in reproductive years suffer from 
PCOS and 75% of the population of infertility 
women with anovulatory case is caused by 
PCOS. A study conducted in Surabaya found that 
prevalence of PCOS in women of reproductive age 
was 4.5%. The prevalence trend of PCOS was 
increased by 6-18%. This was due to the role of 
insulin resistance in the pathophysiology of 
PCOS emergence additionally, an increase in 
insulin resistance was affected by the lifestyle of 
people who diet high in calories with the 
sedentary lifestyle. 
Women with PCOS have an increased 
risk of a number of gynecological neoplasms 
including endometrial, breast and ovarian 
cancers. However, it is quite difficult to explore 
the relationship between the two because cancer 
remains a major postmenopausal women's 
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disease and often occurs long after PCOS 
disappears, only a small proportion of pre-
menopausal women develop cancer along with a 
PCOS diagnosis.2 
The hormone estrogen is a mitogen in the 
endometrium that causes the proliferation of 
glands and stroma. Estrogen also increases the 
expression of Insulin-Like Growth Factor-1 (IGF-
1), which also affects endometrial proliferation. 
Progesterone acts as an antimitogenic, anti-
proliferate and causes endometrial differentiation. 
Progesterone also increases the expression of 
Insulin-Like Growth Factor Binding Protein-1 
(IGFBP-1) that inhibits IGF-1 activity. Other 
researchers extend this theory by suggesting 
hyper androgen increases the potential 
neoplastic changes in the endometrium through 
direct androgenous effects on the endometrium 
and through effects on levels of Sex Hormone 
Binding Globulin (SHBG), circulation IGF-1 and 
estrogen.2  
Herbal therapy became one of the 
alternative treatment issues that are growing very 
rapidly in the community. Researchers in various 
countries seem to be competing to report the 
results of his research that corroborates 
Drumstick Tree as a magical plant. In addition to 
using traditional medicine, there is an evidentially 
based PCOS treatment using Metformin. 
Metformin is the first line treatment of PCOS 
central obesity by inhibiting hepatic glucose 
absorption, increasing peripheral glucose uptake, 
reducing peripheral insulin levels and increasing 
GLUT-4.3 Clinical researchers found the results 
of long-term metformin treatment with indigestion, 
diarrhea and other effects.4 There are no studies 
that prove leaf extract and metformin can 
decrease the expression of IGF-1, the expression 
of the androgen receptor and endometrial 
thickness on the model of PCOS with insulin 
resistance. 
The purpose of this study was to prove 
the effect of Moringa oleifera leaf extract in 
various doses on IGF-1 expression, expression 
of androgen receptor and endometrial thickness 
in PCOS model with insulin resistance.  
 
Materials and methods 
 
Plant material. Moringa oleifera leaf 
extract (Kelorina, PT Moringa Organik Blora 
Central Java Indonesia), which has been 
powdered, all the process was done in 
accordance with the standard to obtain leaf 
extract of Moringa oleifera.10-13 
Animals and experimental protocol. 
Female Rattus norvegicus strains of Wistar 
strains (Laboratory of Biochemistry, Faculty of 
Medicine, Universitas Airlangga) aged 3 months 
weighing 100-150 grams was used as samples. 
Prior to the study, adaptation for 1 week was 
done, healthy conditions with activity, normal 
behavior and results of normal vaginal swab. The 
rat exclusion criteria during adaptation were a 
visible anatomical abnormality and pregnant. 
Maintenance of mice was done in plastic cage 
size 50x30 cm with wood husk pads are changed 
every 4 days, feeding standard and libitum 
drinks. The cage was then placed in a natural 
ventilated room and natural lighting conditions 
(Day & Night) in Biochemistry, Faculty of 
Medicine, Universitas Airlangga.14,15 
Treatment protocol and blood 
collection time points. White rat Wistar strain 
(Rattus norvegicus) was divided randomly into 
five groups (n=8): normal control group was 
given aquades for 14 days, PCOS control group 
with insulin resistance received testosterone 
propionate injection (Testohormon, PT Wonderindo 
Pharmatama, Jakarta, Indonesia) of 1 
mg/100gBB,i.m., on the thigh for 28 days to 
obtain PCOS model with insulin resistance and 
aquades as the therapy. The metformin group 
received a PCOS model with insulin resistance 
and received metformin (2 mg/100gBB, po) for 
14 days, and two treatment groups received 
PCOS models with insulin resistance and therapy 
with Moringa oleifera leaf extract (250 mg/kgBB, 
po) and (500 mg/kgBB, po) for 14 days. Before 
and after the study period, vaginal swabs were 
performed on animals trying to find out what 
cycles were going on. Before the animals were 
sacrificed, they were administered for 12 hours 
and then the endometrial organ was taken for 
examination of endometrial thickness, IGF-1 
expression, and expression of androgen 
receptors. 
Preparation of preparats on each 
parameter. Preparation of histologic preparats 
was using paraffin method with hematoxylin-
eosin staining. The preparation of uterine 
histological preparats with HE staining included 
the fixation stage, dehydration stage, cleaning, 
infiltration, embedding, slicing and staining to 
determine changes in uterine tissue structure and 
calculating the thickness of the endometrium. 
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After the organs in the paraffin blocks were cut 
and placed on the glass object, dephinorization 
and rehydration were performed, then they were 
washed in PBS with pH of 7.4 which followed by 
incubation. Researchers diluted Primary 
Antibodies (IGF-1 and Androgen Receptors) in 
FBS/BSA to desired concentration and volume 
(IGF-1 BS-0014R, 1: 100 antibodies in FBS, 
androgen receptor antibody Ser 791, 1: 100 in 
FBS. Monoclonal Rabbit). Then we diluted the 
secondary antibody labeled biotin in PBS to the 
desired concentration and volume. (Anti Rabbit 
IgG labeled Biotin, SIGMA 1: 500 in PBS). After 
the steps were done, each slide was labeled and 
was dropped the medium mounting (Entellan) 
onto the preparation then it was provided with a 
mounting medium to calculate the amount of 
IGF-1 expression and the amount of expression 
of the androgen receptor in endometrial tissue. 
Statistical anayisis. The Shapiro-wilk 
test was used to test data normality. Statistical 
test using One Way ANOVA/Kruskal-Wallis 
depends on the distribution results. The data 
were considered statistically significant at P value 
<0.05. 
 
Results 
 
Characteristics of experimental animals 
 
The experimental animals in this study 
were three months old female rat of Rattus 
norvegicus that obtained and treated in the 
Biochemistry laboratory of the Faculty of 
Medicine, Airlangga University, Surabaya. The 
mean initial weight of female rat was 112-122 
grams and the final weight of female rat was 174-
196 grams (Table 1). Before a 1 mg/100 
gramBW testohormon was administered, a 
vaginal swab was performed on female rat to 
determine the estrous phase of female rat in 
each group (Figure 1). After the study, vaginal 
swab were performed and the results showed 
that PCOS control group was in the metaestrus 
phase, metformin group was in the diestrus 
phase, the leaf extract group of Moringa oleifera 
250 mg/kgBW was in the diestrus phase, and the 
leaf extract group Moringa oleifera 500 mg/kgBW 
is in the estrus phase. 
 
 
 
Figure 1. The characteristics of Experimental 
Animal based on Swab results before giving 
testohormon. (K1) Normal control group, (K2) 
Group of PCOS, (K3) Metformin group, (K4) 
Group of Moringa oleifera leaf extract 250 
mg/KgBB, (K5) Group of Moringa oleifera leaf 
extract 500 mg/KgBB. 
 
Weight K1 K2 K3 K4 K5 
Initial weight 11.50  121.88 118.63 112.75 119.13 
Final weight 174.25 195.88 195.63 179.00 174.75 
Table 1. The Characteristics of Experimental 
Animals Based on Weight. K1: normal control 
group; K2: PCOS control group-insulin 
resistance; K3: PCOS group-insulin resistance 
given metformin treatment; K4: PCOS group-
insulin resistance was given leaf extract 
treatment of Moringa oleifera 250 mg/kgBB; K5: 
PCOS group-insulin resistance was given leaf 
extract treatment of Moringa oleifera 500 
mg/kgBB 
 
IGF-1 Expression in the Female Rat 
Endometrium of the PCOS Model with Insulin 
Resistance 
 
Measurements of the amount of IGF-1 
Expression using Immunohistochemistry on 
endometrial tissue (Figure 3) were group of 
metformin and Moringa oleifera leaf extract of 
250 mg/kgBW decreased IGF-1 expression 
significantly (P=.000) compared to PCOS control 
group (Table 2). 
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Sample Group  
K1 K2 K3 K4 K5 
Ekspression 
of IGF-1 
13.50± 
1.41 
14.00± 
1.19 
8.63± 
1.59
* 
4.13± 
1.55
* 
13.00± 
1.60 
Table 2. Frequency Distribution Amount of IGF-1 
Expression (%) on PCOS Model with Insulin 
Resistance. Significantly different from PCOS 
control (P<0.05). K1: normal control group; K2: 
PCOS control group-insulin resistance; K3: 
PCOS group-insulin resistance given metformin 
treatment; K4: PCOS group-insulin resistance 
was given leaf extract treatment of Moringa 
oleifera 250 mg/kgBB; K5: PCOS group-insulin 
resistance was given leaf extract treatment of 
Moringa oleifera 500 mg/kgBB. 
 
Figure 2. The characteristics of Experimental 
Animal based on Swab results before euthanasia 
is performed. (K1) Normal control group, (K2) 
Group of PCOS, (K3) Metformin group, (K4) 
Group of Moringa oleifera leaf extract 250 
mg/KgBB, (K5) Group of Moringa oleifera leaf 
extract 500 mg/KgBB. 
 
Expression of androgen receptors in 
the female rat endometrium of the PCOS 
model with insulin resistance 
 
The measurement result of the amount of 
androgen receptor expression using 
Immunohistochemical (IHC) examination on 
endometrial tissue (Figure 4) was that PCOS 
control group significantly increased expression 
of androgen receptor (P=.000) compared to 
normal control group. Group of metformin and 
Moringa oleifera 250 mg/kgBW leaf extract 
showed significantly decreased expression of 
androgen receptors (P=.000) compared with 
PCOS control group (Table 3).  
 
 
Sample 
Group 
K1 K2 K3 K4 K5 
Expression 
of Androgen 
Receptor 
14.13± 
1.13 
18.88± 
1.81
# 
13.88± 
2.42* 
7.13± 
1.46* 
16.25± 
2.87 
Table 3. Frequency Distribution Amount of 
Androgen Receptor Expression (%) on PCOS 
Model with Insulin Resistance. #Significantly 
different from normal control (P<0.05). 
*Significantly different from PCOS control (P<0.05). 
K1: normal control group; K2: PCOS control 
group-insulin resistance; K3: PCOS group-insulin 
resistance given metformin treatment; K4: PCOS 
group-insulin resistance was given leaf extract 
treatment of Moringa oleifera 250 mg/kgBB; K5: 
PCOS group-insulin resistance was given leaf 
extract treatment of Moringa oleifera 500 
mg/kgBB. 
 
 
Figure 3. Immunohistochemical results of IGF-1 
expression. (K1) Normal control group, (K2) 
Group of PCOS, (K3) Metformin group, (K4) 
Group of Moringa oleifera leaf extract 250 
mg/KgBB, (K5) Group of Moringa oleifera leaf 
extract 500 mg/KgBB. 
 
 
Figure 4. Immunohistochemical results of 
Androgen Receptor expression. (K1) Normal 
control group, (K2) Group of PCOS, (K3) 
Metformin group, (K4) Group of Moringa oleifera 
leaf extract 250 mg/KgBB, (K5) Group of Moringa 
oleifera leaf extract 500 mg/KgBB. 
 
The thickness of the endometrium of 
the PCOS model with insulin resistance 
Measurements of endometrial thickness 
using HE (hematoxylin-eosin) examination on 
endometrial tissue (Figure 5), Moringa oleifera 
leaf extract group of 250 mg/kgBW significantly 
decreased the endometrium thickness (P=0.000) 
compared to PCOS control group (Table 4). 
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Sample 
Group 
K1 K2 K3 K4 K5 
Endometrium 
Thickness 
36.34± 
1.76 
32.67± 
5.26 
26.21± 
2.22 
21.90± 
1.39
* 
28. 09± 
5.07 
Table 4. Distribution of Endometrium Thickness 
Frequency (μm) in PCOS Model with Insulin 
Resistance. *Significantly different from PCOS 
control-insulin resistance (P<0.05). K1: normal 
control group; K2: PCOS control group-insulin 
resistance; K3: PCOS group-insulin resistance 
given metformin treatment; K4: PCOS group-
insulin resistance was given leaf extract treatment 
of Moringa oleifera 250 mg/kgBB; K5: PCOS 
group-insulin resistance was given leaf extract 
treatment of Moringa oleifera 500 mg/kgBB. 
 
 
Figure 5. HE results of endometrial thickness 
measured at 400x magnification of the 
microscope and calculated using a micrometer 
scale. (K1) Normal control group, (K2) Group of 
PCOS, (K3) Metformin group, (K4) Group of 
Moringa oleifera leaf extract 250 mg/KgBB, (K5) 
Group of Moringa oleifera leaf extract 500 
mg/KgBB. 
 
 Discussion 
 
 Moringa oleifera leaf extract can decrease 
the expression of IGF-1 in endometrium PCOS 
model with insulin resistance. The results of the 
study were the extract of Moringa oleifera leaf 
extract could decrease expression of androgen 
receptor on PCOS model endometrium with insulin 
resistance, PCOS control group had significantly 
increased androgen receptor compared to normal 
control group. This suggests that the PCOS 
control group undergoes hyper androgenic. The 
incidence of hyper androgenic is followed by 
increasing androgen receptor in the tissues. 
According to Yongli's study of 17 patients with 
PCOS and 20 controls, there was an increase in 
serum testosterone levels, increased expression 
of androgen receptor and a significant increase in 
insulin resistance index in the PCOS group 
compared to the control group and there was a 
positive relationship between them.5 
The PCOS control group with the normal 
control group did not show any significant 
difference, but the PCOS control group's average 
outcome improved slightly compared to the 
normal control group. This is because the 
presence of hyperandrogen can lead to 
increased IGF-1 expression in the endometrium. 
The longer the exposure to androgen resulted in 
the expression of IGF-1 increased in the 
endometrium. In this study, androgen exposure 
was performed for 28 days, so that endometrial 
target organ which is a long-term complication of 
PCOS has not been obtained. Moringa leaf 
extract has many very beneficial ingredients for 
health, namely vitamins, minerals, amino acids 
and other antioxidant compounds, especially 
quercetin, which in some studies has the benefit 
of reducing IGF-1 directly so that it can inhibit the 
process of proliferation in the endometrium. This 
is in accordance with the positive effects of 
curettin that can interact with IGF-1 signaling so 
as to inhibit the proliferation of tissue.6  
The metformin group and the group of 
Moringa oleifera 250 mg/kgBB leaf extract 
significantly decreased the expression of the 
androgen receptor compared to the PCOS 
control group. Moringa oleifera leaf extract can 
decrease expression of androgen receptors in 
endometrial tissue. In the leaf extract contains 
polyphenols quercetin which can reduce 
androgen hormone levels through the path 
PI3K/akt. 
Moringa oleifera leaf extract can decrease 
the endometrial thickness of PCOS model with 
insulin resistance. The PCOS control group did 
not show significant differences compared to the 
normal control group, but based on the average 
results there was a slight decrease in 
endometrial thickness in the PCOS control group 
compared to the normal control group. It 
happened because the relationship between 
endometrial cancer and PCOS is caused by 
chronic stimulation of endometrial growth due to 
unopposed estrogen conditions. Although PCOS 
is the most common cause of anovulation, and 
anovulation is the most common cause of 
endometrial hyperplasia, it does not mean that all 
women with PCOS have a high risk of 
endometrial malignancies, because the 
prevalence of endometrial carcinoma in women 
with PCOS is low.7 Provision of testohormon for 
28 days has not revealed any unopposed 
estrogen condition caused by the occurrence of 
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anovulation in the PCOS model in accordance 
with the results of the study in the PCOS group 
experienced decreased endometrial thickness. 
One of the long-term effects of PCOS is 
endometrial hyperplasia arising from prolonged 
exposure to estrogen without progesterone 
support, the duration of this estrogen exposure 
may be due to hyper androgen. 
Long-term unopposed estrogen stimulation 
of the endometrium will cause patients to have a 
high risk of endometrial malignancy. The hormone 
estrogen is a mitogen in the endometrium that 
causes the proliferation of glands and stroma. 
Estrogen also increases the expression of 
Insulin-Like Growth Factor-1 (IGF-1) which 
affects endometrial proliferation. Progesterone 
acts as an antimitogenic, antiproliferation, and 
causes endometrial differentiation. Progesterone 
also increases the expression of Insulin-Like 
Growth Factor Binding Protein-1 (IGFBP-1) that 
inhibits IGF-1 activity. This study did not show 
the state of unopposed estrogen so it does not 
appear endometrial hyperplasia. 
The group of Moringa oleifera leaf extract 
250mg/kgBB showed a significant decrease in 
endometrium thickness compared with PCOS 
control group. Moringa oleifera leaf extract 
containing some minerals, vitamins, proteins and 
antioxidants such as polyphenols. One of the 
polyphenols is quercetin which can directly inhibit 
the work of IGF-1 so that it affects the 
proliferation of tissue, such as the endometrial 
tissue. Quersetin can also directly affect the 
proliferation of tissue. The results showed that 
leaf extract of Moringa oleifera 500mg/KgBB 
could decrease expression of IGF-1, expression 
of Androgen receptor and endometrial thickness 
compared to PCOS control group, but did not 
show a significant difference. This may be due to 
the prooxidant effect of methanol from Moringa 
oleifera leaf extract 500mg/KgBB which can 
cause oxidative stress. Other extracts of Moringa 
oleifera leaf extracts such as quercetin also have 
a pro-oxidant effect on high-dose administration 
by producing ROS through auto oxidants and 
cyclic redox.8 Pro-oxidant effects are not always 
dangerous because the formation of ROS may 
be selective against cancer cells, so it will 
produce antioxidants to help the body's defence 
system.9  
 
  
 
Conclusions 
 
Moringa oleifera leaf extract could 
decrease the expression of IGF-1 and expression 
of androgen receptor in the endometrial of PCOS 
model with insulin resistance, so that endometrial 
thickness in PCOS model decreased with 
significant dose in Moringa oleifera leaf extract 
250 mg/KgBW. 
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